Drug Shortage Report for TEVA-LETROZOLE
Report ID | 183404 |
Drug Identification Number | 02343657 |
Brand name | TEVA-LETROZOLE |
Common or Proper name | LETROZOLE 2.5MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LETROZOLE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | pp 30 |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-30 |
Estimated end date | 2023-10-30 |
Actual end date | 2023-10-05 |
Shortage status | Resolved |
Updated date | 2023-10-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-02-02 | English | Compare |
v2 | 2023-02-02 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v4 | 2023-02-09 | French | Compare |
v5 | 2023-02-16 | English | Compare |
v6 | 2023-02-16 | French | Compare |
v7 | 2023-04-27 | English | Compare |
v8 | 2023-04-27 | French | Compare |
v9 | 2023-07-27 | English | Compare |
v10 | 2023-07-27 | French | Compare |
v11 | 2023-08-08 | English | Compare |
v12 | 2023-08-08 | French | Compare |
v13 | 2023-10-06 | English | Compare |
v14 | 2023-10-06 | French | Compare |
Showing 1 to 14 of 14